NCT01880515 2025-05-11
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Instituto Nacional de Cancerologia de Mexico
Phase 2 Completed
Instituto Nacional de Cancerologia de Mexico
Cyprus University of Technology
Asan Medical Center
Impaqtt Foundation
British Columbia Cancer Agency
Memorial Sloan Kettering Cancer Center
Mt. Sinai Medical Center, Miami